# Roxadustat Combined With Sacubitril Valsartan Sodium Tablets in the Treatment of Cardiorenal Anemia Syndrome

> **NCT05053893** · NA · UNKNOWN · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 40 (estimated)

## Conditions studied

- Cardio-Renal Syndrome

## Interventions

- **DRUG:** Roxadustat;Sacubitril Valsartan Sodium Tablets;
- **DRUG:** EPO; ACEI / ARB

## Key facts

- **NCT ID:** NCT05053893
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-22
- **Primary completion:** 2022-07-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05053893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05053893, "Roxadustat Combined With Sacubitril Valsartan Sodium Tablets in the Treatment of Cardiorenal Anemia Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05053893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*